Agios Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 26, 2023
Filed with the SEC on Apr 26, 2023 and accepted by EDGAR at Apr 26, 2023, 16:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-23-118490. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.